Breaking up is hard to do

Lessons learned from a pharma-free practice transformation

David Evans, Daniel M. Hartung, Denise Beasley, Lyle Fagnan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Academic medical centers are examining relationships with the pharmaceutical industry and making changes to limit interactions. Most doctors, however, practice outside of academic institutions and see pharmaceutical detailers and accept drug samples and gifts. Little guidance for practicing physicians exists about transforming practices to become pharma-free. Consideration must be given to the impact on practice culture, staff views, and patient needs. Methods: A small private practice, setting out to transform into a pharma-free clinic, used a practice transformation process that examined the industry presence in the clinic, educated the doctors on potential conflicts of interest, and improved practice flow. Staff were given the opportunity to share concerns, and their issues were acknowledged. Educational interventions were developed to help providers keep current. Finally, efforts were made to educate patients about the policy. Results: The clinic recorded the degree to which it was detailed. Loss of gifts, keeping current with new drugs, and managing without samples were noted concerns. Policy change champions developed strategies to address concerns. Discussion: A shift in practice culture to a pharma-free clinic is achievable and maintainable over time. Barriers to success can be identified and overcome with attention given to careful gathering of information, staff input, and stakeholder education.

Original languageEnglish (US)
Pages (from-to)332-338
Number of pages7
JournalJournal of the American Board of Family Medicine
Volume26
Issue number3
DOIs
StatePublished - May 2013

Fingerprint

Gift Giving
Pharmaceutical Preparations
Conflict of Interest
Private Practice
Drug Industry
Industry
Physicians
Education

Keywords

  • Conflict of Interest
  • Drug Industry
  • Medical Ethics
  • Practice Management

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Family Practice

Cite this

Breaking up is hard to do : Lessons learned from a pharma-free practice transformation. / Evans, David; Hartung, Daniel M.; Beasley, Denise; Fagnan, Lyle.

In: Journal of the American Board of Family Medicine, Vol. 26, No. 3, 05.2013, p. 332-338.

Research output: Contribution to journalArticle

@article{062b090de56a43be85d3823c116be3ab,
title = "Breaking up is hard to do: Lessons learned from a pharma-free practice transformation",
abstract = "Background: Academic medical centers are examining relationships with the pharmaceutical industry and making changes to limit interactions. Most doctors, however, practice outside of academic institutions and see pharmaceutical detailers and accept drug samples and gifts. Little guidance for practicing physicians exists about transforming practices to become pharma-free. Consideration must be given to the impact on practice culture, staff views, and patient needs. Methods: A small private practice, setting out to transform into a pharma-free clinic, used a practice transformation process that examined the industry presence in the clinic, educated the doctors on potential conflicts of interest, and improved practice flow. Staff were given the opportunity to share concerns, and their issues were acknowledged. Educational interventions were developed to help providers keep current. Finally, efforts were made to educate patients about the policy. Results: The clinic recorded the degree to which it was detailed. Loss of gifts, keeping current with new drugs, and managing without samples were noted concerns. Policy change champions developed strategies to address concerns. Discussion: A shift in practice culture to a pharma-free clinic is achievable and maintainable over time. Barriers to success can be identified and overcome with attention given to careful gathering of information, staff input, and stakeholder education.",
keywords = "Conflict of Interest, Drug Industry, Medical Ethics, Practice Management",
author = "David Evans and Hartung, {Daniel M.} and Denise Beasley and Lyle Fagnan",
year = "2013",
month = "5",
doi = "10.3122/jabfm.2013.03.120268",
language = "English (US)",
volume = "26",
pages = "332--338",
journal = "Journal of the American Board of Family Medicine",
issn = "1557-2625",
publisher = "American Board of Family Medicine",
number = "3",

}

TY - JOUR

T1 - Breaking up is hard to do

T2 - Lessons learned from a pharma-free practice transformation

AU - Evans, David

AU - Hartung, Daniel M.

AU - Beasley, Denise

AU - Fagnan, Lyle

PY - 2013/5

Y1 - 2013/5

N2 - Background: Academic medical centers are examining relationships with the pharmaceutical industry and making changes to limit interactions. Most doctors, however, practice outside of academic institutions and see pharmaceutical detailers and accept drug samples and gifts. Little guidance for practicing physicians exists about transforming practices to become pharma-free. Consideration must be given to the impact on practice culture, staff views, and patient needs. Methods: A small private practice, setting out to transform into a pharma-free clinic, used a practice transformation process that examined the industry presence in the clinic, educated the doctors on potential conflicts of interest, and improved practice flow. Staff were given the opportunity to share concerns, and their issues were acknowledged. Educational interventions were developed to help providers keep current. Finally, efforts were made to educate patients about the policy. Results: The clinic recorded the degree to which it was detailed. Loss of gifts, keeping current with new drugs, and managing without samples were noted concerns. Policy change champions developed strategies to address concerns. Discussion: A shift in practice culture to a pharma-free clinic is achievable and maintainable over time. Barriers to success can be identified and overcome with attention given to careful gathering of information, staff input, and stakeholder education.

AB - Background: Academic medical centers are examining relationships with the pharmaceutical industry and making changes to limit interactions. Most doctors, however, practice outside of academic institutions and see pharmaceutical detailers and accept drug samples and gifts. Little guidance for practicing physicians exists about transforming practices to become pharma-free. Consideration must be given to the impact on practice culture, staff views, and patient needs. Methods: A small private practice, setting out to transform into a pharma-free clinic, used a practice transformation process that examined the industry presence in the clinic, educated the doctors on potential conflicts of interest, and improved practice flow. Staff were given the opportunity to share concerns, and their issues were acknowledged. Educational interventions were developed to help providers keep current. Finally, efforts were made to educate patients about the policy. Results: The clinic recorded the degree to which it was detailed. Loss of gifts, keeping current with new drugs, and managing without samples were noted concerns. Policy change champions developed strategies to address concerns. Discussion: A shift in practice culture to a pharma-free clinic is achievable and maintainable over time. Barriers to success can be identified and overcome with attention given to careful gathering of information, staff input, and stakeholder education.

KW - Conflict of Interest

KW - Drug Industry

KW - Medical Ethics

KW - Practice Management

UR - http://www.scopus.com/inward/record.url?scp=84877766899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877766899&partnerID=8YFLogxK

U2 - 10.3122/jabfm.2013.03.120268

DO - 10.3122/jabfm.2013.03.120268

M3 - Article

VL - 26

SP - 332

EP - 338

JO - Journal of the American Board of Family Medicine

JF - Journal of the American Board of Family Medicine

SN - 1557-2625

IS - 3

ER -